Belkin International Inc. v. Kappos,
Fed. Cir., No. 2012-1090, 10/2/12
A patent reexamination is limited to answering the substantial new question of patentability determined by the Patent and Trademark Office director, the U.S. Court of Appeals for the Federal Circuit ruled Oct. 2 (Belkin International Inc. v. Kappos, Fed. Cir., No. 2012-1090, 10/2/12).
Affirming a decision by the Board of Patent Appeals and Interferences, the court faulted the petitioner in an inter partes reexamination for failing to take advantage of a PTO procedure allowing a challenge to the agency's determination of what did not create a new patentability question.
In January 2008, OptimumPath filed a patent infringement lawsuit against seven companies, including Belkin International Inc., Cisco Linksys LLC, D-Link Systems Inc., and Netgear Inc., in the U.S. District Court for the District of South Carolina. No. 4:09-cv-01398-CW (D.S.C., complaint filed Jan. 30, 2008).
Those four defendants filed a request with the PTO for inter partes reexamination of the '281 patent in October 2008. They argued that all 32 of the claims of the patent were not patentable for anticipation or obviousness in light of four references.
The PTO determined that another U.S. patent (6,560,217) issued to Kenneth L. Peirce Jr. and assigned to 3Com Corp. raised a substantial new question (SNQ) of patentability as to six of the claims. It accordingly ordered reexamination on those six claims for anticipation by the Peirce patent, but it also rejected the argument that the other three proffered references raised a SNQ on any of the 32 claims.
Belkin requested a review of the denial of reexamination to the other 26 claims, which the PTO also denied.
The central reexamination unit examiner assigned to the case looked only at the Peirce patent and confirmed the patentability of the six claims that were subject to reexamination. Belkin appealed to the BPAI, arguing that the examiner should have looked at the other three references.
The board rejected the appeal and also affirmed the examiner's findings with respect to Peirce.
Belkin then appealed to the Federal Circuit.
One question at issue related to the actions Belkin took or could have taken after the PTO decision on whether a SNQ had been raised. Under the PTO's Rule 1.927, 37 C.F.R. §1.927, Belkin was permitted to file a petition for review of that decision, the court noted. However, its petition for review at that point did not challenge the part of the PTO's decision that concluded that the other three references did not raise a SNQ, including as to the six claims in reexamination.
Under 35 U.S.C. §312(c), the court said, the PTO's SNQ decision was not appealable to the Federal Circuit. Thus, the court determined that the only relevant question in this appeal was whether, when a SNQ is raised as to some claims, the examiner should consider all the references proffered in the inter partes request.
The court acknowledged that the scope of reexamination can conceivably encompass not only what the requester proffered but also what the PTO director raises on his own initiative. “It otherwise may not include other prior art than what constituted the basis of the Director's determination of a substantial question of patentability,” the court concluded.
In this case, the court explained, the SNQ applied only to anticipation by Peirce, so the reexamination was properly limited to answering that question.
“But that provision does not discuss the preclusive effect of a determination that an issue does not raise a substantial new question of patentability,” the court said. And regardless, it added, “the MPEP does not have the force of law.”
“[W]e hold that, under the statute, available prior art may only be considered to answer the specific questions of patentability found by the Director,” the court said.
Chief Judge Randall R. Rader and Judge Evan J. Wallach joined the opinion.
David L. McCombs of Haynes and Boone, Dallas, represented Belkin. PTO Associate Solicitor Scott C. Weidenfeller represented the PTO. Tony D. Alexander of Technology Legal Counsel LLC, Augusta, Ga., represented OptimumPath.
By Tony Dutra
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).